The process of NAFLD development closely correlates with postmenopausal and circulating proinflammatory mediators, which are TNF-α, IL-1β, and IL-6 [31,32,33]. The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatotic liver disease.